Clinical Trial Update: Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating U01(ssCART-19) for B-cell lymphoma is ongoing. The study is currently recruiting at Shanghai Tongji Hospital and Tongji Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma

Drugs mentioned

• U01 (ssCART-19)

Snippet

Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine | Conditions: B Cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING